Abstract:Different animal models have been used for hair research and regeneration studies based on the similarities between animal and human skins. Primary knowledge on hair follicle (HF) biology has arisen from research using mouse models baring spontaneous or genetically engineered mutations. These studies have been crucial for the discovery of genes underlying human hair cycle control and hair loss disorders. Yet, researchers have become increasingly aware that there are distinct architectural and cellular features… Show more
“…In addition to this, MJ04 was seen to dampen the level of proinflammatory cytokines, i.e., TNF-α, IL1-β, and IL-6 in the LPS primed macrophages, thereby reiterating its role in effectively inhibiting polarization of naïve T-cells into the proinflammatory immunophenotypes in order to reinstate the immune homeostasis and manage the autoimmune inflammatory response associated with induction of alopecia areata [ 49 , 50 ]. Among several strains of mice, C57BL/6 and C3H mouse strains are most frequently used for understanding hair biology and are commonly used for hair research [ 51 ]. Although several procedures and protocols have been established using mouse models, but these models still lack in providing actual representations of disease conditions.…”
JAK-STAT signalling pathway inhibitors have emerged as promising therapeutic agents for the treatment of hair loss. Among different JAK isoforms, JAK3 has become an ideal target for drug discovery because it only regulates a narrow spectrum of γc cytokines. Here, we report the discovery of MJ04, a novel and highly selective 3-pyrimidinylazaindole based JAK3 inhibitor, as a potential hair growth promoter with an IC50 of 2.03 nM. During in vivo efficacy assays, topical application of MJ04 on DHT-challenged AGA and athymic nude mice resulted in early onset of hair regrowth. Furthermore, MJ04 significantly promoted the growth of human hair follicles under ex-vivo conditions. MJ04 exhibited a reasonably good pharmacokinetic profile and demonstrated a favourable safety profile under in vivo and in vitro conditions. Taken together, we report MJ04 as a highly potent and selective JAK3 inhibitor that exhibits overall properties suitable for topical drug development and advancement to human clinical trials.
“…In addition to this, MJ04 was seen to dampen the level of proinflammatory cytokines, i.e., TNF-α, IL1-β, and IL-6 in the LPS primed macrophages, thereby reiterating its role in effectively inhibiting polarization of naïve T-cells into the proinflammatory immunophenotypes in order to reinstate the immune homeostasis and manage the autoimmune inflammatory response associated with induction of alopecia areata [ 49 , 50 ]. Among several strains of mice, C57BL/6 and C3H mouse strains are most frequently used for understanding hair biology and are commonly used for hair research [ 51 ]. Although several procedures and protocols have been established using mouse models, but these models still lack in providing actual representations of disease conditions.…”
JAK-STAT signalling pathway inhibitors have emerged as promising therapeutic agents for the treatment of hair loss. Among different JAK isoforms, JAK3 has become an ideal target for drug discovery because it only regulates a narrow spectrum of γc cytokines. Here, we report the discovery of MJ04, a novel and highly selective 3-pyrimidinylazaindole based JAK3 inhibitor, as a potential hair growth promoter with an IC50 of 2.03 nM. During in vivo efficacy assays, topical application of MJ04 on DHT-challenged AGA and athymic nude mice resulted in early onset of hair regrowth. Furthermore, MJ04 significantly promoted the growth of human hair follicles under ex-vivo conditions. MJ04 exhibited a reasonably good pharmacokinetic profile and demonstrated a favourable safety profile under in vivo and in vitro conditions. Taken together, we report MJ04 as a highly potent and selective JAK3 inhibitor that exhibits overall properties suitable for topical drug development and advancement to human clinical trials.
Alopecia, commonly known as hair loss, presents a multifaceted challenge affecting millions worldwide. Recent advances in hair loss treatment and prevention offer hope to individuals grappling with this condition. This comprehensive overview delves into the causes of hair loss, encompassing genetics, hormonal imbalances, nutritional deficiencies, stress, and underlying medical conditions. The COVID-19 pandemic has also revealed unique patterns of hair loss i.e., telogen effluvium, prompting ongoing research and therapeutic exploration.Current treatment options, including medications like minoxidil and finasteride, surgical interventions such as hair transplants, and non-surgical techniques like laser therapy and platelet-rich plasma therapy, are examined in detail. While effective, these treatments come with limitations and potential side effects, necessitating careful consideration.Looking ahead, researchers are exploring innovative approaches to combat hair loss, from targeted medications to gene therapies and stem cell-based interventions. Advanced delivery methods using nanotechnology and biomaterials hold promise for more effective and safer solutions in the future.Recognizing the psychological impact of hair loss, this review emphasizes the importance of addressing the emotional aspects of this condition to enhance overall patient well-being. The future holds the potential for more holistic and successful treatments in the ongoing battle against hair loss, offering optimism to those seeking solutions.
“…The mesodermal dermis is composed of various connective tissues with slower proliferating cells, in combination with other structures built from various other cell types, including blood vessels cells, glands, neural sensors and resident cells of the immune system. Radiation induced changes can be reflected in the organization of the structures and the width of the different skin layers, as dictated by the proliferation rate of the cells, their death rate, and the regeneration of appendages such as hair follicles [ 4 , 5 ]. Damages to the skin inflicted by high-dose ionizing radiation in different animal models, were found to derive from combined insults to various cell types, with acute expression of damages to the faster proliferating epidermal cells [ 6 ].…”
Skin exposure to high-dose irradiation, as commonly practiced in radiotherapy, affects the different skin layers, causing dry and wet desquamation, hyperkeratosis fibrosis, hard to heal wounds and alopecia and damaged hair follicles. Fetal tissue mesenchymal stromal cells (f-hPSC) were isolated from excised human fetal placental tissue, based on their direct migration from the tissue samples to the tissue dish. The current study follows earlier reports on for the mitigation of acute radiation syndrome following whole body high-dose exposure with remotely injected f-hPSC. Both the head only and a back skin flap of mice were irradiated with 16 &18 Gy, respectively, by 6MeV clinical linear accelerator electron beam. In both locations, the irradiated skin areas developed early and late radiation induced skin damages, including cutaneous fibrosis, lesions, scaring and severe hair follicle loss and reduced hair pigmentation. Injection of 2 × 106 f-hPSC, 3 and 8 weeks following 16 Gy head irradiation, and 1 and 4 weeks following the 18 Gy back skin only irradiation, resulted in significantly faster healing of radiation induced damages, with reduction of wet desquamation as measured by surface moisture level and minor recovery of the skin viscoelasticity. Detailed histological morphometry showed a clear alleviation of radiation induced hyperkeratosis in f-hPSC treated mice, with significant regain of hair follicles density. Following 16 Gy head irradiation, the hair follicles density in the scalp skin was reduced significantly by almost a half relative to the controls. A nearly full recovery of hair density was found in the f-hPSC treated mice. In the 18 Gy irradiated back skin, the hair follicles density dropped in a late stage by ~70% relative to naïve controls. In irradiated f-hPSC treated mice, it was reduced by only ~30% and was significantly higher than the non-treated group. Our results suggest that local injections of xenogeneic f-hPSC could serve as a simple, safe and highly effective non-autologous pro-regenerative treatment for high-dose radiation induced skin insults. We expect that such treatment could also be applied for other irradiated organs.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.